Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

21.34
+0.11000.52%
Post-market: 21.340.00000.00%19:30 EDT
Volume:571.85K
Turnover:12.30M
Market Cap:1.36B
PE:-9.11
High:22.12
Open:21.45
Low:21.13
Close:21.23
52wk High:28.00
52wk Low:6.91
Shares:63.60M
Float Shares:47.12M
Volume Ratio:0.62
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3433
EPS(LYR):-3.1931
ROE:-89.18%
ROA:-33.59%
PB:0.47
PE(LYR):-6.68

Loading ...

Jade Biosciences - Enters Exclusive Worldwide License Agreement with Paragon Therapeutics - SEC Filing

THOMSON REUTERS
·
Jul 02

Jade Biosciences Secures Exclusive Antibody License Agreement

TIPRANKS
·
Jul 02

Jade Biosciences Licenses Paragon Antibody Program, with up to $22 Million in Milestones

Reuters
·
Jul 02

Jade Biosciences Director Mark Eisner Files Initial Beneficial Ownership Statement

Reuters
·
Jun 27

Jade Biosciences Announces Appointment of Mark Eisner, M.d., M.p.h., to Board of Directors

THOMSON REUTERS
·
Jun 26

Press Release: Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.p.h., to Board of Directors

Dow Jones
·
Jun 26

Jade Biosciences Inc : UBS Initiates Coverage With Buy Rating and Target Price $45

THOMSON REUTERS
·
Jun 15

Jade Biosciences Initiated at Buy by UBS

Dow Jones
·
Jun 15

Jade Biosciences initiated with a Buy at UBS

TIPRANKS
·
Jun 15

Jade Biosciences Shareholders Approve Governance and Audit Measures

TIPRANKS
·
Jun 12

Jade Biosciences updates bylaws to allow virtual meetings, drops pre-meeting voter list requirement

Reuters
·
Jun 12

Analysts Offer Insights on Healthcare Companies: Olema Pharmaceuticals (OLMA), Jade Biosciences (JBIO) and Oculis Holding (OCS)

TIPRANKS
·
Jun 06

Jade Biosciences Closes Public Offering of Shares

MT Newswires Live
·
Jun 06

Press Release: Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Dow Jones
·
Jun 06

Jade Biosciences Launches Major Underwritten Equity Offering

TIPRANKS
·
Jun 05

Is Jade Biosciences (JBIO) Fairly Priced As Shares Swing And Losses Mount?

Simply Wall St.
·
Jun 05

JADE101 Phase 1 Trial Marks Key Early Milestone for Jade Biosciences Investors

TIPRANKS
·
Jun 05

BUZZ-U.S. STOCKS ON THE MOVE-UnitedHealth,  Pinterest, Celcuity

Reuters
·
Jun 04

Jade Biosciences 10M share Secondary priced at $15.00

TIPRANKS
·
Jun 04

Jade Biosciences prices 10 million-share follow-on at $15, raising $150 million gross

Reuters
·
Jun 04